Contact 
Locations .png){kind=icon}
Call Treatment Guide
Component-Resolved Diagnostics (CRD)
Component-resolved diagnostics are blood tests that measure IgE to selected allergen proteins rather than only to a whole allergen extract. CRD can refine a specific diagnostic question, but results still require the reaction history, current tolerance, and clinical interpretation.
Understanding Component-Resolved Diagnostics (CRD)
Component-Resolved Diagnostics (CRD): what the first evaluation should clarify
What component testing can add
For selected foods or pollens, components may help distinguish primary sensitization from cross-reactivity and support a decision about avoidance, challenge, or treatment. The usefulness depends on the allergen and clinical question.
What the result cannot predict
A component result does not diagnose allergy without a compatible history and cannot reliably predict the exact severity of a future reaction. Larger panels can still identify irrelevant sensitization.
Care Options
How the test fits the pathway
The clinician first reviews the event, prior skin or blood testing, tolerated exposures, and the decision that remains. A blood sample is then selected only if the additional component information is likely to change care.
Component-Resolved Diagnostics (CRD) planning questions
Build the component-resolved diagnostics (crd) next step from evidence
Whole-allergen and component tests answer different questions
A whole-allergen test measures IgE binding to a mixture of proteins from the source. Component testing measures selected individual proteins and may help distinguish a stable storage protein from a cross-reactive pollen-related protein in specific clinical situations.
Not every allergen has clinically useful components, and the available panel may not include the protein responsible for a patient’s reaction.
Results do not predict an exact reaction
A component result changes probability; it does not guarantee tolerance, predict the dose that will trigger symptoms, or determine the exact severity of a future reaction. Values from different laboratories, assays, ages, and populations cannot be treated as universal pass-fail cutoffs.
The result must be interpreted with the food or venom history, exposure amount, later tolerance, other test results, and the decision the patient is trying to make.
Know the Next Step
When component testing may change management
Useful questions may include whether a positive peanut or tree-nut test could reflect pollen cross-reactivity, which venom sensitization pattern best matches a sting history, or whether additional evidence would inform a supervised challenge discussion. It should not be used as a broad screening panel in someone who eats the foods without symptoms.
Ask the ordering clinician what each selected component could change before the blood is drawn and how the result will be communicated.
Care Connected with Component-Resolved Diagnostics (CRD)
Evaluation and treatment related to Component-Resolved Diagnostics (CRD)
These diagnostic and treatment topics can shape a focused component-resolved diagnostics (crd) discussion.
Allergy Blood Testing and Specific IgE Results
Allergy Blood Testing and Specific IgE Results can clarify a separate question that often appears while evaluating Component-Resolved Diagnostics (CRD).
View guideFood Allergy Testing and Evaluation
Use the Food Allergy Testing and Evaluation guide to compare preparation, evidence, and next steps alongside Component-Resolved Diagnostics (CRD).
View guideOral Food Challenges
Open Oral Food Challenges for connected testing or treatment decisions that may follow a Component-Resolved Diagnostics (CRD) discussion.
View guidePatient guide
Component-Resolved Diagnostics (CRD): decisions, preparation, and safety
Quick answer
CRD can sometimes distinguish protein patterns that suggest primary sensitization from patterns more consistent with cross-reactivity. It is an add-on tool for selected questions, not a universal panel that diagnoses every allergy.
Who may want to ask about it
The test may be useful when whole-extract results and the history do not agree, pollen-related cross-reactivity is suspected, multiple related foods are being evaluated, or more detail could help decide whether a supervised challenge is reasonable.
What the visit or test may answer
The clinician first identifies the unresolved decision. Existing skin tests, whole-allergen IgE, component results, foods eaten safely, reaction timing, preparation, amount, and cofactors are reviewed together before more testing is ordered.
How to prepare
Bring original laboratory reports with units and reference ranges, the exact foods or exposures involved, labels or photographs, a list of tolerated related foods, and records of treatment received during prior reactions.
Limits and safety
A positive component shows sensitization, not automatically clinical allergy. A number cannot predict the exact symptoms or severity of a future reaction and should not be used alone to remove a tolerated food.
When symptoms need urgent care
CRD is not an emergency test and does not guide treatment during a reaction. Severe symptoms require the patient’s emergency action plan and immediate care.
Alternatives to discuss
Depending on the question, alternatives include focused history, skin-prick testing, whole-allergen IgE, repeat testing over time, a basophil activation test where available, or a medically supervised oral food challenge.
A useful next step
Ask which component is being considered, what uncertainty it addresses, how the result would change the plan, and whether either possible result would still leave a food challenge or follow-up decision.
Know What the Test Measures
Whole-allergen IgE versus allergen components
A whole-allergen blood test measures IgE binding to a mixture of proteins from a source such as peanut, hazelnut, milk, egg, or pollen. A component test measures IgE to one or more selected proteins within that source. This molecular detail can be helpful when different proteins have different stability, cross-reactivity, or associations with clinical allergy.
More detail is not automatically more accurate. The usefulness varies by allergen, population, laboratory method, and clinical question. A component result should be ordered because it can change a decision, not because a larger panel feels more complete. The allergy blood testing guide explains the broader distinction between sensitization and clinical allergy.
Use CRD for Defined Questions
When component testing may add useful information
Current food-allergy guidance recognizes selected components as useful supporting tests. Examples include Ara h 2 for peanut, Cor a 14 for hazelnut, and Ana o 3 for cashew, especially when pollen sensitization or cross-reactivity makes a whole-extract result harder to interpret. These examples do not create universal cutoffs and do not allow patients to interpret a report without their history.
CRD may also help distinguish primary sensitization from a pollen-food pattern, explore cross-reactivity among related sources, or refine the probability discussion before an oral food challenge. For respiratory allergy, molecular patterns may help separate genuine sensitization from cross-reactive proteins when that distinction would affect immunotherapy selection.
Avoid Overdiagnosis
What component testing cannot tell you
Component testing cannot determine with certainty whether a person will react, what the next reaction will look like, or how severe it will be. Test values overlap between people who react and people who tolerate the food. Age, prevalence, prior reactions, current tolerance, and the reason the test was ordered all affect interpretation.
Large multiplex panels can reveal sensitization to proteins that have never caused symptoms. That can lead to unnecessary avoidance, anxiety, nutritional burden, and more testing. A patient who regularly tolerates a food should not remove it solely because an unexpected component result appears, unless the treating clinician identifies a specific reason and explains the next step.
Connect the Result to a Decision
How CRD may influence a food challenge or avoidance plan
The reference standard for an uncertain IgE-mediated food allergy remains a medically supervised oral food challenge. A component result may increase or decrease estimated probability, but it does not replace the clinician’s assessment of challenge benefit, asthma control, recent reactions, family readiness, and the resources required for a safe procedure.
After interpretation, the plan should state what is confirmed, what remains uncertain, which foods can continue, whether follow-up testing is useful, and what evidence would support a challenge. If avoidance continues, the clinician can also review nutrition, label reading, emergency preparedness, and whether another treatment discussion is appropriate.
Read the Report in Context
Single components, multiplex panels, units, and trends
Some laboratories test one selected component at a time, while multiplex platforms examine many molecules from a smaller sample. Results from different platforms are not necessarily interchangeable. Units, reporting limits, calibration, and the tested protein matter, so screenshots or copied values without the full report can be misleading.
A change over time may be useful for a defined follow-up question, but repeat testing should not become a substitute for clinical review. Ask whether the same method was used, whether the change is large enough to matter, and what decision the trend is expected to influence.
Compare the Options
Choosing the test that answers the question
These tools provide different kinds of evidence. The clinician decides which, if any, is needed.
| Tool | What it measures or observes | Main limitation |
|---|---|---|
| Skin-prick test | Immediate skin response to selected allergen extracts or materials | Shows sensitization and depends on technique, medicines, and skin response |
| Whole-allergen IgE | Blood IgE binding to a mixture of proteins from one source | May not separate primary sensitization from cross-reactivity |
| Component-resolved diagnostics | Blood IgE to selected individual allergen proteins | Clinical value varies by component and does not prove reaction or severity |
| Oral food challenge | Observed response while measured food portions are given under supervision | Requires preparation, time, medical resources, and an individualized risk-benefit decision |
Patient questions
Frequently asked questions about Component-Resolved Diagnostics (CRD)
What does component-resolved diagnostics mean?
It means measuring IgE to selected individual allergen proteins rather than only to a whole extract. The additional detail can refine certain food, pollen, or cross-reactivity questions.
Is component testing more accurate than a standard allergy test?
Not for every question. It provides a different level of detail. Its value depends on the allergen, component, history, and decision that remains after standard evaluation.
Does a positive component result prove I have an allergy?
No. It proves sensitization to that protein. Clinical allergy requires a compatible history or clarification through an appropriate diagnostic pathway.
Can CRD predict how severe my next reaction will be?
No. Some patterns are associated with different probabilities, but a component result cannot reliably predict the exact symptoms or severity of a future reaction.
What are Ara h 2, Cor a 14, and Ana o 3?
They are named allergen proteins from peanut, hazelnut, and cashew. Current guidance recognizes them as potentially useful supporting tests in selected settings, but interpretation is individualized.
Can component testing tell whether symptoms are pollen-food allergy syndrome?
It may support that distinction for selected foods and pollen-related proteins, but the actual foods, preparation, symptom location, timing, and pollen history remain essential.
Do I need a large component panel?
Usually the better question is which result could change care. Broad panels increase the chance of finding sensitization that is not clinically relevant.
Can I eat a food if the component result is low?
A number alone does not establish safety. A clinician should combine it with the history and may recommend continued intake, avoidance, follow-up, or a supervised challenge.
Do antihistamines affect a component blood test?
Antihistamines generally do not suppress serum allergen-specific IgE in the way they can affect skin testing, but follow the ordering clinician’s instructions and do not change medication without guidance.
Plan the next component-resolved diagnostics (crd) conversation
Bring the symptom, reaction, testing, and treatment records named in this Component-Resolved Diagnostics (CRD) guide so the visit can answer a focused question.
Live Well
Request a consultation with our team.
